Massachusetts' biotech leadership faces rising competition as China accelerates its sector

Massachusetts has long been recognized as a global biotech hub. The state’s ecosystem includes leading research institutions and firms. Recent analysis suggests China is narrowing the advantage. Chinese investments and talent are expanding its biotech capabilities. The Boston Globe points to growing competition between the two regions. Both areas aim to attract funding and scientific breakthroughs. Policy makers are watching the shifting dynamics closely. The rivalry could reshape global biotech innovation pathways.